CRYO-CELL INTERNATIONAL, INC. Financing Cash Flow
CRYO-CELL INTERNATIONAL, INC. (CCEL) reported Financing Cash Flow of -$2.36 million for the 6-month period ending 2026-05-31, per its 10-Q filed 2026-07-15.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-07-15
- CRYO-CELL INTERNATIONAL, INC. net cash provided by (used in) financing activities for the quarter ending 2026-05-31 was -$1.62M, a 328.59% decline year-over-year.
- CRYO-CELL INTERNATIONAL, INC. net cash provided by (used in) financing activities for the quarter ending 2026-02-28 was -$740.29K.
- CRYO-CELL INTERNATIONAL, INC. net cash provided by (used in) financing activities for the quarter ending 2025-11-30 was -$937.34K.
- CRYO-CELL INTERNATIONAL, INC. net cash provided by (used in) financing activities for the quarter ending 2025-08-31 was -$3.51M.
- CRYO-CELL INTERNATIONAL, INC. net cash provided by (used in) financing activities for fiscal 2025 was -$4.75M.
- CRYO-CELL INTERNATIONAL, INC. net cash provided by (used in) financing activities for fiscal 2024 was -$979.12K.
- CRYO-CELL INTERNATIONAL, INC. net cash provided by (used in) financing activities for fiscal 2023 was -$2.07M, a 1501.91% decline from fiscal 2022.
- CRYO-CELL INTERNATIONAL, INC. net cash provided by (used in) financing activities for fiscal 2022 was $147.86K.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|---|
| 2026-05-31 | -$1.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-15 | -$2.36M 10-Q · filed 2026-07-15 | -$3.30M derived: sum of 3 quarters · filed 2026-07-15 | -$6.81M derived: sum of 4 quarters · filed 2026-07-15 | |
| 2026-02-28 | -$740.29K 10-Q · filed 2026-04-14 | -$1.68M derived: sum of 2 quarters · filed 2026-04-14 | -$5.19M derived: sum of 3 quarters · filed 2026-04-14 | -$4.48M derived: sum of 4 quarters · filed 2026-07-15 | |
| 2025-11-30 | -$937.34K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$4.45M derived: sum of 2 quarters · filed 2026-02-27 | -$3.74M derived: sum of 3 quarters · filed 2026-07-15 | -$4.75M 10-K · filed 2026-02-27 | |
| 2025-08-31 | -$3.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-15 | -$2.80M derived: sum of 2 quarters · filed 2026-07-15 | -$3.81M 10-Q · filed 2025-10-15 | -$4.49M derived: sum of 4 quarters · filed 2026-07-15 | |
| 2025-05-31 | $710.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-15 | -$294.26K 10-Q · filed 2026-07-15 | -$972.08K derived: sum of 3 quarters · filed 2026-07-15 | -$3.02M derived: sum of 4 quarters · filed 2026-07-15 | |
| 2025-02-28 | -$1.00M 10-Q · filed 2026-04-14 | -$1.68M derived: sum of 2 quarters · filed 2026-04-14 | -$3.73M derived: sum of 3 quarters · filed 2026-04-14 | -$2.52M derived: sum of 4 quarters · filed 2026-04-14 | |
| 2024-11-30 | -$677.82K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$2.72M derived: sum of 2 quarters · filed 2026-02-27 | -$1.52M derived: sum of 3 quarters · filed 2026-02-27 | -$979.12K 10-K · filed 2026-02-27 | |
| 2024-08-31 | -$2.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-15 | -$840.26K derived: sum of 2 quarters · filed 2025-10-15 | -$301.30K 10-Q · filed 2025-10-15 | -$1.84M derived: sum of 4 quarters · filed 2025-10-15 | |
| 2024-05-31 | $1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-15 | $1.74M 10-Q · filed 2025-07-15 | $201.49K derived: sum of 3 quarters · filed 2025-07-15 | $1.11M derived: sum of 4 quarters · filed 2025-07-15 | |
| 2024-02-29 | $538.96K 10-Q · filed 2025-04-14 | -$1.00M derived: sum of 2 quarters · filed 2025-04-14 | -$97.85K derived: sum of 3 quarters · filed 2025-04-14 | -$761.09K derived: sum of 4 quarters · filed 2025-04-14 | |
| 2023-11-30 | -$1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$636.81K derived: sum of 2 quarters · filed 2025-02-28 | -$1.30M derived: sum of 3 quarters · filed 2025-02-28 | -$2.07M 10-K · filed 2025-02-28 | |
| 2023-08-31 | $903.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-15 | $240.62K derived: sum of 2 quarters · filed 2024-10-15 | -$532.23K 10-Q · filed 2024-10-15 | -$6.10M derived: sum of 4 quarters · filed 2024-10-15 | |
| 2023-05-31 | -$663.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-15 | -$1.44M 10-Q · filed 2024-07-15 | -$7.00M derived: sum of 3 quarters · filed 2024-07-15 | $1.66M derived: sum of 4 quarters · filed 2024-07-15 | |
| 2023-02-28 | -$772.85K 10-Q · filed 2024-04-15 | -$6.34M derived: sum of 2 quarters · filed 2024-04-15 | $2.32M derived: sum of 3 quarters · filed 2024-04-15 | $947.00K derived: sum of 4 quarters · filed 2024-04-15 | |
| 2022-11-30 | -$5.57M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $3.09M derived: sum of 2 quarters · filed 2024-02-28 | $1.72M derived: sum of 3 quarters · filed 2024-02-28 | $147.86K 10-K · filed 2024-02-28 | |
| 2022-08-31 | $8.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-12 | $7.29M derived: sum of 2 quarters · filed 2023-10-12 | $5.71M 10-Q · filed 2023-10-12 | $4.90M derived: sum of 4 quarters · filed 2023-10-12 | |
| 2022-05-31 | -$1.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-14 | -$2.94M 10-Q · filed 2023-07-14 | -$3.76M derived: sum of 3 quarters · filed 2023-07-14 | -$4.53M derived: sum of 4 quarters · filed 2023-07-14 | |
| 2022-02-28 | -$1.57M 10-Q · filed 2023-04-21 | -$2.39M derived: sum of 2 quarters · filed 2023-04-21 | -$3.16M derived: sum of 3 quarters · filed 2023-04-21 | -$3.06M derived: sum of 4 quarters · filed 2023-04-21 | |
| 2021-11-30 | -$814.25K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$1.59M derived: sum of 2 quarters · filed 2023-02-28 | -$1.49M derived: sum of 3 quarters · filed 2023-02-28 | -$3.07M 10-K · filed 2023-02-28 | |
| 2021-08-31 | -$775.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-18 | -$675.33K derived: sum of 2 quarters · filed 2022-10-18 | -$2.26M 10-Q · filed 2022-10-18 | -$3.03M derived: sum of 4 quarters · filed 2022-10-18 | |
| 2021-05-31 | $99.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-11 | -$1.48M 10-Q · filed 2022-07-11 | -$2.26M derived: sum of 3 quarters · filed 2022-07-11 | -$4.98M derived: sum of 4 quarters · filed 2022-07-11 | |
| 2021-02-28 | -$1.58M 10-Q · filed 2022-04-13 | -$2.36M derived: sum of 2 quarters · filed 2022-04-13 | -$5.08M derived: sum of 3 quarters · filed 2022-04-13 | -$5.85M derived: sum of 4 quarters · filed 2022-04-13 | |
| 2020-11-30 | -$775.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | -$3.50M derived: sum of 2 quarters · filed 2022-02-22 | -$4.27M derived: sum of 3 quarters · filed 2022-02-22 | -$5.00M 10-K · filed 2022-02-22 | |
| 2020-08-31 | -$2.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-15 | -$3.49M derived: sum of 2 quarters · filed 2021-10-15 | -$4.23M 10-Q · filed 2021-10-15 | -$6.00M derived: sum of 4 quarters · filed 2021-10-15 | |
| 2020-05-31 | -$775.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-15 | -$1.51M 10-Q · filed 2021-07-15 | -$3.28M derived: sum of 3 quarters · filed 2021-07-15 | -$5.10M derived: sum of 4 quarters · filed 2021-07-15 | |
| 2020-02-29 | -$734.00K 10-Q · filed 2021-04-14 | -$2.50M derived: sum of 2 quarters · filed 2021-04-14 | -$4.32M derived: sum of 3 quarters · filed 2021-04-14 | -$5.10M derived: sum of 4 quarters · filed 2021-04-14 | |
| 2019-11-30 | -$1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$3.59M derived: sum of 2 quarters · filed 2021-03-01 | -$4.36M derived: sum of 3 quarters · filed 2021-03-01 | -$5.13M 10-K · filed 2021-03-01 | |
| 2019-08-31 | -$1.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-15 | -$2.59M derived: sum of 2 quarters · filed 2020-10-15 | -$3.36M 10-Q · filed 2020-10-15 | -$3.32M 10-Q · filed 2019-10-15 | -$5.14M derived: sum of 4 quarters · filed 2020-10-15 |
| 2019-05-31 | -$775.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-10 | -$1.54M 10-Q · filed 2020-07-10 | -$3.32M derived: sum of 3 quarters · filed 2020-07-10 | $5.16M derived: sum of 4 quarters · filed 2020-07-10 | |
| 2019-02-28 | -$769.30K 10-Q · filed 2020-04-14 | -$2.54M derived: sum of 2 quarters · filed 2020-04-14 | $5.94M derived: sum of 3 quarters · filed 2020-04-14 | $5.44M derived: sum of 4 quarters · filed 2020-04-14 | |
| 2018-11-30 | -$1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $6.71M derived: sum of 2 quarters · filed 2020-02-28 | $6.21M derived: sum of 3 quarters · filed 2020-02-28 | $5.71M 10-K · filed 2020-02-28 | |
| 2018-08-31 | $8.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-15 | $7.98M derived: sum of 2 quarters · filed 2019-10-15 | $7.48M 10-Q · filed 2019-10-15 | $7.00M derived: sum of 4 quarters · filed 2019-10-15 | |
| 2018-05-31 | -$497.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-15 | -$995.08K 10-Q · filed 2019-07-15 | -$1.48M derived: sum of 3 quarters · filed 2019-07-15 | -$2.67M derived: sum of 4 quarters · filed 2019-07-15 | |
| 2018-02-28 | -$497.75K 10-Q · filed 2019-04-15 | -$984.45K derived: sum of 2 quarters · filed 2019-04-15 | -$2.18M derived: sum of 3 quarters · filed 2019-04-15 | ||
| 2017-11-30 | -$486.70K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$1.68M derived: sum of 2 quarters · filed 2019-02-28 | -$3.03M 10-K · filed 2019-02-28 | ||
| 2017-08-31 | -$1.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-15 | -$2.55M 10-Q · filed 2018-10-15 | |||
| 2017-05-31 | -$1.35M 10-Q · filed 2018-07-16 | ||||
| 2013-11-30 | -$66.55K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | -$67.53K derived: sum of 2 quarters · filed 2014-02-28 | -$476.62K derived: sum of 3 quarters · filed 2014-02-28 | -$723.67K 10-K · filed 2014-02-28 | |
| 2013-08-31 | -$975.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-15 | -$410.07K derived: sum of 2 quarters · filed 2013-10-15 | -$657.12K 10-Q · filed 2013-10-15 | -$1.08M derived: sum of 4 quarters · filed 2014-02-28 | |
| 2013-05-31 | -$409.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-15 | -$656.14K 10-Q · filed 2013-07-15 | -$1.08M derived: sum of 3 quarters · filed 2014-02-28 | -$1.63M derived: sum of 4 quarters · filed 2014-02-28 | |
| 2013-02-28 | -$247.04K 10-Q · filed 2013-04-15 | -$673.29K derived: sum of 2 quarters · filed 2014-02-28 | -$1.22M derived: sum of 3 quarters · filed 2014-02-28 | -$2.14M derived: sum of 4 quarters · filed 2014-02-28 | |
| 2012-11-30 | -$426.24K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | -$974.50K derived: sum of 2 quarters · filed 2014-02-28 | -$1.90M derived: sum of 3 quarters · filed 2014-02-28 | -$4.95M 10-K · filed 2014-02-28 | |
| 2012-08-31 | -$548.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-15 | -$1.47M derived: sum of 2 quarters · filed 2013-10-15 | -$4.52M 10-Q · filed 2013-10-15 | -$4.47M derived: sum of 4 quarters · filed 2013-10-15 | |
| 2012-05-31 | -$922.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-15 | -$3.98M 10-Q · filed 2013-07-15 | -$3.92M derived: sum of 3 quarters · filed 2013-07-15 | -$3.90M derived: sum of 4 quarters · filed 2013-07-15 | |
| 2012-02-29 | -$3.05M 10-Q · filed 2013-04-15 | -$3.00M derived: sum of 2 quarters · filed 2013-04-15 | -$2.98M derived: sum of 3 quarters · filed 2013-04-15 | ||
| 2011-11-30 | $58.17K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $75.47K derived: sum of 2 quarters · filed 2013-02-28 | $80.94K 10-K · filed 2013-02-28 | ||
| 2011-08-31 | $17.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-15 | $22.76K 10-Q · filed 2012-10-15 | |||
| 2011-05-31 | $5.47K 10-Q · filed 2012-07-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |